TY - JOUR
T1 - The development of colitis in Il10 −/− mice is dependent on IL-22
AU - Gunasekera, Dilini C.
AU - Ma, Jinxia
AU - Vacharathit, Vimvara
AU - Shah, Palak
AU - Ramakrishnan, Amritha
AU - Uprety, Priyanka
AU - Shen, Zeli
AU - Sheh, Alexander
AU - Brayton, Cory F.
AU - Whary, Mark T.
AU - Fox, James G.
AU - Bream, Jay H.
N1 - Publisher Copyright:
© 2020, Society for Mucosal Immunology.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Mice deficient in the IL-10 pathway are the most widely used models of intestinal immunopathology. IL-17A is strongly implicated in gut disease in mice and humans, but conflicting evidence has drawn IL-17’s role in the gut into question. IL-22 regulates antimicrobial and repair activities of intestinal epithelial cells (IECs) and is closely associated with IL-17A responses but it’s role in chronic disease is uncertain. We report that IL-22, like IL-17A, is aberrantly expressed in colitic Il10−/− mice. While IL-22+Th17 cells were elevated in the colon, IL-22-producing ILC3s were highly enriched in the small intestines of Il10−/− mice. Remarkably, Il10−/−Il22−/− mice did not develop colitis despite retaining high levels of Th17 cells and remaining colonized with colitogenic Helicobacter spp. Accordant with IL-22-induced IEC proliferation, the epithelia hyperplasia observed in Il10−/− animals was reversed in Il10−/−Il22−/− mice. Also, the high levels of antimicrobial IL-22-target genes, including Reg3g, were normalized in Il10−/−Il22−/− mice. Consistent with a heightened antimicrobial environment, Il10−/− mice had reduced diversity of the fecal microbiome that was reestablished in Il10−/−Il22−/− animals. These data suggest that spontaneous colitis in Il10−/− mice is driven by IL-22 and implicates an underappreciated IL-10/IL-22 axis in regulating intestinal homeostasis.
AB - Mice deficient in the IL-10 pathway are the most widely used models of intestinal immunopathology. IL-17A is strongly implicated in gut disease in mice and humans, but conflicting evidence has drawn IL-17’s role in the gut into question. IL-22 regulates antimicrobial and repair activities of intestinal epithelial cells (IECs) and is closely associated with IL-17A responses but it’s role in chronic disease is uncertain. We report that IL-22, like IL-17A, is aberrantly expressed in colitic Il10−/− mice. While IL-22+Th17 cells were elevated in the colon, IL-22-producing ILC3s were highly enriched in the small intestines of Il10−/− mice. Remarkably, Il10−/−Il22−/− mice did not develop colitis despite retaining high levels of Th17 cells and remaining colonized with colitogenic Helicobacter spp. Accordant with IL-22-induced IEC proliferation, the epithelia hyperplasia observed in Il10−/− animals was reversed in Il10−/−Il22−/− mice. Also, the high levels of antimicrobial IL-22-target genes, including Reg3g, were normalized in Il10−/−Il22−/− mice. Consistent with a heightened antimicrobial environment, Il10−/− mice had reduced diversity of the fecal microbiome that was reestablished in Il10−/−Il22−/− animals. These data suggest that spontaneous colitis in Il10−/− mice is driven by IL-22 and implicates an underappreciated IL-10/IL-22 axis in regulating intestinal homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=85078062025&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078062025&partnerID=8YFLogxK
U2 - 10.1038/s41385-019-0252-3
DO - 10.1038/s41385-019-0252-3
M3 - Article
C2 - 31932715
AN - SCOPUS:85078062025
SN - 1933-0219
VL - 13
SP - 493
EP - 506
JO - Mucosal Immunology
JF - Mucosal Immunology
IS - 3
ER -